van Til, N. P. Et Al. 2010. Lentiviral gene therapy of murine hematopoietic stem cells ameliorates the Pompe disease phenotype. BLOOD , vol.115, no.26 , 5329-5337.

van Til, N. P., Stok, M., Kaya, F. S. F. A., de Waard, M. C., Farahbakhshian, E., Visser, T. P., ... Kroos, M. A.(2010). Lentiviral gene therapy of murine hematopoietic stem cells ameliorates the Pompe disease phenotype. BLOOD , vol.115, no.26, 5329-5337.

van Til, Niek Et Al. "Lentiviral gene therapy of murine hematopoietic stem cells ameliorates the Pompe disease phenotype," BLOOD , vol.115, no.26, 5329-5337, 2010

van Til, Niek P. Et Al. "Lentiviral gene therapy of murine hematopoietic stem cells ameliorates the Pompe disease phenotype." BLOOD , vol.115, no.26, pp.5329-5337, 2010

van Til, N. P. Et Al. (2010) . "Lentiviral gene therapy of murine hematopoietic stem cells ameliorates the Pompe disease phenotype." BLOOD , vol.115, no.26, pp.5329-5337.

@article{article, author={Niek P. van Til Et Al. }, title={Lentiviral gene therapy of murine hematopoietic stem cells ameliorates the Pompe disease phenotype}, journal={BLOOD}, year=2010, pages={5329-5337} }